Amid the threat of pharmaceutical tariffs from President Donald Trump, recent months have seen multibillion-dollar U.S.

UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...

UCB, a global biopharmaceutical company focused on improving the lives of people with severe diseases, today announced plans for a significant investment in a new, state-of-the-art biologics ...

The Pontifical Catholic University of Puerto Rico (PUCPR) announced it will expand into the island’s metropolitan region ...

United Commercial Bank (UCB) could not recommend any dividend for shareholders for the year ending 31 December 2024 due to a significant provision shortfall. According to the bank's disclosure, a ...

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...

Two Sigma Investments LP purchased a new position in United Community Banks, Inc. (NASDAQ:UCB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 8,708 shares of the ...

Spain’s SpliceBio will use $135 million from a series B round backed by Sanofi and Roche to advance its lead gene editing ...

Bottlerocket Social Hall partners with Upright Citizens Brigade, securing investment for a Pittsburgh comedy training center ...

We recently wrote an introductory overview of navigating the Common Law Research Exemption and the Hatch-Waxman Safe Harbor ...

United Community Banks (UCB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...